Disc Medicine
Kevin Clarke currently serves as the Executive Director of Strategic Accounts & Access at Disc Medicine since September 2025. Prior to this role, Kevin held the position of Executive Director for US Market Access & Reimbursement at Alexion Pharmaceuticals, Inc. from September 2019 to September 2025. Kevin's extensive experience includes leadership positions at Intercept Pharmaceuticals, ThromboGenics, Acorda Therapeutics, Endo Pharmaceuticals, and Genentech, where responsibilities spanned market access, reimbursement, and regional account management. Kevin holds a Bachelor of Arts degree in History and Political Science from the University of Rhode Island, obtained between 1988 and 1992.
This person is not in any teams
This person is not in any offices